Last reviewed · How we verify

Injectable polio vaccine and Bivalent oral polio vaccine

Aga Khan University · FDA-approved active Biologic Quality 5/100

Injectable polio vaccine and Bivalent oral polio vaccine is a Biologic drug developed by Aga Khan University. It is currently FDA-approved.

At a glance

Generic nameInjectable polio vaccine and Bivalent oral polio vaccine
SponsorAga Khan University
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Injectable polio vaccine and Bivalent oral polio vaccine

What is Injectable polio vaccine and Bivalent oral polio vaccine?

Injectable polio vaccine and Bivalent oral polio vaccine is a Biologic drug developed by Aga Khan University.

Who makes Injectable polio vaccine and Bivalent oral polio vaccine?

Injectable polio vaccine and Bivalent oral polio vaccine is developed and marketed by Aga Khan University (see full Aga Khan University pipeline at /company/aga-khan-university).

What development phase is Injectable polio vaccine and Bivalent oral polio vaccine in?

Injectable polio vaccine and Bivalent oral polio vaccine is FDA-approved (marketed).

Related